Vets Choice

Quick links to important sections

Vets Choice

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Vets Choice

Property Description
Active ingredient Ivermectin
Form Topical Solution (Pour-On)
Pharmacological class Endectocide (Macrocyclic Lactone)
Common use Broad-spectrum parasite control in cattle
Origin Semisynthetic derivative (from Streptomyces avermitilis)

What Type of Medicine is Vets Choice?

Vets Choice is a specialized veterinary medicine defined by its active component, Ivermectin, which is formally classified as an Endectocide—a type of drug with broad-spectrum effectiveness against both internal and external parasites. Ivermectin is a semisynthetic derivative that belongs to the macrocyclic lactone chemical group, originally isolated from the Streptomyces avermitilis bacterium. Ivermectin's unique structure has been the subject of intensive pharmacological studies, recognizing its distinction from earlier classes of anthelmintics. This characterizes the drug's established use as a powerful agent for clearing a wide range of parasitic burdens.


Composition and Form: The Ivermectin Pour-On Solution

The defining characteristic of Vets Choice is its Pour-On Topical Solution dosage form, which dictates its route of administration is cutaneous application onto the animal's topline. The composition features the active ingredient Ivermectin dissolved in a specialized solvent-based vehicle. This solvent vehicle is engineered to ensure the active compound absorbs efficiently through the skin and into the systemic circulation, a feature particularly desirable for non-invasive treatment of large herds. This specific form, intended for veterinary use only in cattle, offers a distinct advantage over oral or injectable Ivermectin preparations by simplifying application logistics.


General Benefit: Broad-Spectrum Parasite Control

The general purpose of Vets Choice is the comprehensive management of the parasitic burden in cattle. As an endectocide, its fundamental benefit is the ability to simultaneously address a wide variety of infestations, including gastrointestinal roundworms and external organisms like lice and mites. Ivermectin’s unique mode of action involves binding selectively to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells. This physiological action leads directly to the paralysis and subsequent death of the parasitic organisms, serving the essential purpose of efficient and robust parasite control for animal health.

What side effects are possible with Vets Choice?

Possible Side Effects and Safety Information

The official safety profile for Vets Choice (Ivermectin Pour-On) primarily describes adverse reactions based on the site of application and potential systemic effects as documented in regulatory sources.


Frequency-Classified Adverse Reactions

The majority of documented effects are categorized as Common and are related to the topical application. These include transient discomfort or irritation and local swelling or edema at the site of administration. Less common reactions may involve alopecia (hair loss) in the treated area.


Systemic and Serious Safety Considerations

Adverse effects are officially grouped within System-Organ Classes such as Skin and Subcutaneous Tissue Disorders and Nervous System Disorders. Serious adverse reactions, though rare, are documented, particularly those associated with specific host-parasite interactions. The destruction of certain parasites (Hypoderma larvae) in vital tissues may cause host reactions like staggering or paralysis, as noted in official labels.


Population and Regulatory Restrictions

The safety profile includes specific limitations on use. The product is not permitted for use in lactating dairy cows producing milk for human consumption, nor is it recommended for use in non-target species. The formulation is explicitly classified as a highly flammable liquid and carries a significant environmental toxicity warning regarding aquatic life. A mandatory slaughter withdrawal period must be observed before treated cattle may enter the food supply.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — official regulatory information for Vets Choice

Overdose scope

Category Description (Strictly Regulatory-Derived)
Documented overdose presentations Systemic disturbances (asthenia, headache, dizziness), gastrointestinal effects (nausea, vomiting, diarrhea, abdominal pain), and neurological signs (ataxia, blurred vision). Dermal reactions such as rash and edema are also documented.
Physiological systems affected (as stated in label) Central Nervous System (CNS), Gastrointestinal (GI), Cardiovascular, Respiratory, and Dermal/Integumentary systems.
Dose-related or exposure-related factors (if applicable) The documented risk profile is primarily associated with accidental human exposure to concentrated veterinary formulations.
Population-specific overdose notes (if applicable) The described symptom profile is derived from cases of accidental human ingestion or significant exposure to concentrated animal products.
Emergency-response statements (as written in official documents) Contact a physician immediately or call a Poison Control Center for advice concerning cases of ingestion.
When immediate medical help is required (label-derived phrasing only) Immediate medical treatment must be sought if any product has been taken and symptoms are experienced, especially for life-threatening signs such as seizure, collapse, or trouble breathing.

Overdose classifications (high-level)

Category Description (Strictly Regulatory-Derived)
Severity classification (as defined in official documents) The official documents classify the event as potentially severe, referencing outcomes including respiratory failure, seizure, and coma.
Regulatory basis (EMA / FDA / etc.) FDA / NIH DailyMed and CDC Health Advisories.
Overdose-context constraints (as defined in official documents) The described profile is relevant to overexposure and requires management through supportive therapy to limit absorption and stabilize the patient.

Resulting overdose structure

Official overdose statements:

  • Overdose may escalate to serious outcomes including seizure, decreased consciousness, respiratory failure, and clinically significant hypotension.
  • No specific antidote for Ivermectin overdose is known.
  • Procedural management may include induction of emesis and/or gastric lavage, followed by purgatives and other routine anti-poison measures to limit absorption.
  • Supportive therapy involves parenteral fluids, electrolytes, and pressor agents for hypotension, with respiratory support if necessary.

Connection to the overall overdose profile (3 sentences): Regulatory documents define the overdose profile by listing the specific systemic and CNS manifestations that may occur following exposure, which may escalate to life-threatening clinical outcomes. Consequently, the profile explicitly mandates the immediate emergency help-seeking for severe symptoms. The official label further details regulator-defined supportive management procedures, including decontamination and respiratory support, due to the recognized absence of a specific antidote.

Therapeutic Uses of Vets Choice

Vets Choice (a type of glucocorticoid medication) is commonly used to help manage a wide range of veterinary health concerns that involve symptoms related to inflammatory or irritative states. The core therapeutic utility is based on its anti-inflammatory and immunosuppressive characteristics, which helps address symptom clusters that may become intense or disruptive.

This medication’s indications comprise the various collagen, dermal, allergic, ocular, otic, and musculoskeletal conditions involving inflammatory or irritative processes. It may assist with managing certain symptoms related to systemic imbalance, such as those involved in acute adrenal insufficiency, and is applied in addressing conditions presenting with systemic or localized discomfort. This treatment is often used when symptoms intensify and supportive relief is needed. Overall, the treatment contributes to improved comfort during periods of heightened symptoms and assists with maintaining functional stability.

“This medication is considered relevant for easing discomfort in scenarios involving heightened systemic burden.”

Quick Fact: Relief for Symptoms related to physical discomfort

Regulatory References

  1. FDA-approved DailyMed Monograph for Prednisolone

Eligibility and Restrictions for Use

The eligibility profile for Vets Choice (Ivermectin Pour-On for Cattle) is defined by strict regulatory parameters concerning species, physiological status, and the prevention of drug residues in the human food supply.

The medicine is contraindicated for use in humans and non-cattle species (such as dogs), where Ivermectin is associated with severe adverse reactions. Its application is confined solely to beef cattle and non-lactating dairy cattle.

Population Eligibility Classification Restriction Basis
Humans / Other Species Contraindicated Safety/Species Prohibition
Lactating Dairy Cattle Do Not Use Milk Withdrawal Time Not Established
Veal Calves Do Not Use Pre-Ruminant Withdrawal Not Established

Eligibility is restricted by the meat withdrawal period. Cattle must not be treated within the designated pre-slaughter interval (typically 48 days) to ensure no residues enter the food supply. Furthermore, use is not established in pre-ruminating calves. Application is restricted on animals with a wet hide or severe skin lesions, as regulatory data indicates the treatment's efficacy may be compromised. Use in breeding animals (bulls and cows) is generally permitted.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Officially documented interaction patterns for Vets Choice (Ivermectin Pour-On) are defined by constraints on co-administered treatments and environmental conditions that officially affect drug exposure and efficacy. The regulatory profile notes that co-administration with the anticoagulant Warfarin has been associated with post-marketing reports of an increased International Normalized Ratio (INR). This observation is classified as a pharmacodynamic effect documented with other systemic medicinal products.

Regulatory labeling establishes several exposure-modifying restrictions related to the administration environment. The product's intended antiparasitic activity is officially impaired if the topical solution is applied over adherent materials (such as caked mud or manure), mange scabs, lesions, or dermatoses on the skin. These conditions compromise the required absorption and reduce the systemic bioavailability of Ivermectin.

Furthermore, a specific environmental constraint is documented: the efficacy of the product is officially reduced if the treated animal is exposed to rain or wetness within two hours of administration, establishing a mandatory timing rule. Official labeling also includes a specific restriction regarding population sensitivity; the product is not recommended for use in species other than cattle due to documented severe adverse reactions in certain non-target species.

Mechanism of Action

Targeting Parasite-Specific Ion Channels

The core mechanism involves Ivermectin acting as an agonist that selectively binds to glutamate-gated chloride channels ( GluCls), which are primarily found in the nerve and muscle cells of parasites. This binding forces the channel pore to remain open, initiating the molecular cascade that results in the specific physiological consequence of the drug.


The Cascade of Neuromuscular Blockade

The sustained opening of the GluCls allows a continuous, massive influx of chloride ions ( Cl^-) into the parasite's cells, leading to severe cell hyperpolarization and electrical silencing. This ultimately results in an irreversible flaccid paralysis, preventing the parasite from moving, feeding, or maintaining attachment to the host, which contributes to the overall physiological disruption of the parasite's systems.


Mechanism Selectivity and Constraint

This mechanism is defined by its high degree of specificity for invertebrate GluCls, which structurally differ from the analogous ion channels in mammalian hosts, which determines the specific target-dependent boundaries of the action. The mechanism is constrained, however, by the life cycle; the paralyzing cascade is less relevant for stages like eggs or pupae that lack active neuromuscular function.

Dosage and Administration Information

Vets Choice is administered solely via topical application, a route strictly defined by the product's Pour-On Solution formulation. This medication is intended for external use only on cattle, and the official instructions prohibit administration through oral or injectable routes. The fundamental principle governing use is accurate weight-based dosing, which is necessary to ensure the therapeutic standard of 500 mu g of ivermectin per kilogram of the animal's body weight is delivered.

This dose translates directly into the volume of solution to be applied. For instance, when using a 5 mg/mL concentration, the required volume is 1 mL for every 22 lb of body weight. The application site is precisely defined: the solution must be applied along the animal’s topline in a narrow strip running from the withers to the tailhead. When treating a group of cattle, the dose calculation must be based on the heaviest animal in the group to prevent underdosing.

The efficacy of the topical application is conditional on the state of the animal and the environment. It is specified that the product should not be applied when the hair or hide is wet, as this condition can impair the necessary absorption of the active ingredient. Vets Choice is typically used as a single application treatment, often integrated into a broader parasite control program. The treatment schedule is controlled, and the minimum time required before any subsequent treatment is generally not less than 42 days, a requirement that reflects established veterinary use protocol. This standardized approach ensures administration strictly adheres to established application standards.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Vets Choice


Evidence for Use in Gastrointestinal Roundworm Infections

Research has examined the use of the medicine against gastrointestinal roundworm infections (nematodes) in cattle. This was primarily investigated through Randomized Controlled Trials (RCTs) and Controlled Efficacy Studies. These studies were used to measure how the parasite burden evolved in the observed animal populations. In these controlled research settings, studies consistently described measurements indicating a reduction in parasite levels following administration of the pour-on formulation, based on metrics like Fecal Egg Count Reduction (FECR).

Evidence for Use in External Parasite Infestations

Research also explored the use of Vets Choice against external parasite infestations, such as lice, mites, and horn flies. The research base includes Efficacy Studies and Controlled Field Trials. The studies reported that the medicine was observed to be associated with a measured decrease in the counts of targeted external parasites following the pour-on application. The research for this use appears to be dependent on achieving proper topical application, which is a variable factor in field research.

Evidence for Re-infection Prevention and Persistent Activity

The research has examined the potential for re-infection prevention by conducting Controlled Field Trials and specific Duration of Activity Studies. These studies monitored the time taken for re-infection to occur for specific parasites. They reported on the measured time intervals over which a reduced parasite level was observed in some studies against specific internal and external parasites. The research cited in regulatory documentation for persistent activity is often categorized as having moderate certainty.

What Remains Uncertain About Vets Choice Research

Research highlights what is known, but evidence also indicates important gaps. The certainty remains low for certain aspects, particularly the long-term outcomes and the durability of the observed effect beyond the intermediate follow-up periods reported in the efficacy trials. Efficacy measurements for the formulation are subject to variability based on external application factors, such as the condition of the hide. Furthermore, the literature documents the need for continued research regarding the management of anthelmintic resistance and the limited information on pharmacokinetic profiles in diverse cattle populations.

Key Studies & References

  1. Ivermectin Pour-On for Cattle (Ivermectin 5.00 mg/mL) - Canadian Regulatory Document (Source of Indications, Dosing, and Persistent Activity Claims)
  2. IVOMEC® (ivermectin) Pour-On for Cattle Label (Source of Specific Persistent Activity Durations for Internal and External Parasites)
  3. Label: IVERMECTIN POUR-ON FOR CATTLE- ivermectin solution - DailyMed (FDA-Approved Labeling for Indications and Safety Warnings)

Frequently Asked Questions (FAQ)

Common questions about Vets Choice (FAQ)


Q: I missed a dose of Vets Choice—what should I do?

A: Vets Choice is a pour-on formulation that is typically administered as a single, one-time application for parasite control in cattle. Official regulatory documents do not provide instruction for managing a 'missed dose' because the treatment is not generally intended to be part of a long-term, multi-day dosing regimen.

Q: Is Vets Choice available over the counter in any country?

A: Official labeling states that Vets Choice is strictly for veterinary use. It directs owners to consult with their veterinarian for assistance with diagnosis and treatment, which is consistent with its status as a veterinary-controlled product.

Q: What kind of warnings should I look out for while taking Vets Choice?

A: Official product warnings include that the product is highly flammable and poses an environmental toxicity risk to aquatic life. Regulatory warnings specify that Vets Choice is not for human use and should be stored securely out of the reach of children. Adverse reactions, such as transient skin irritation or discomfort at the application site, are also documented in the safety information.

Q: What is the minimum age Vets Choice is typically prescribed for?

A: Official labeling prohibits the use of Vets Choice in calves intended to be processed for veal, as a residue withdrawal period has not been established for pre-ruminating calves. A general minimum age for all beef cattle populations is not otherwise provided in the official instructions.

Q: Are there known allergic reactions to Vets Choice I should be aware of?

A: Official product information on adverse reactions reports common effects like transient discomfort, irritation, and local swelling (edema) at the site of application. Serious reactions, such as staggering or paralysis, are also documented, particularly when the death of certain parasites in vital tissues triggers a host reaction. While irritation is noted, official documents generally describe this as a local adverse reaction rather than a systemic allergic reaction.

Q: Why is Vets Choice sometimes only prescribed for a short course?

A: The pour-on formulation is typically indicated as a single application. The product information indicates that the single application is intended to control parasites, and it is not generally prescribed as part of a chronic or long-term medication course.

Q: Are there any generic versions of Vets Choice available yet?

A: Regulatory documentation, such as FDA ANADA submissions, indicates that generic versions containing the active ingredient Ivermectin Pour-On for Cattle are approved and considered therapeutically equivalent to the pioneer product.

Q: Does the efficacy of Vets Choice change with different formulations (e.g., tablet vs. liquid)?

A: Vets Choice is officially only available and tested as a Pour-On Topical Solution, which is applied to the animal's skin. The efficacy of the product is specifically tied to this formulation and its reliance on proper topical application to the hide.

Q: Can taking Vets Choice cause stomach upset even when taken with food?

A: Vets Choice is a pour-on solution intended strictly for application to the skin surface (topical). Official labeling explicitly prohibits giving this product orally or by injection, meaning concerns about stomach upset from ingestion are not relevant to its intended use.

Q: I'm pregnant/nursing—what is the general guidance on Vets Choice?

A: The official label includes specific use restrictions concerning calving and milk production. Vets Choice is strictly prohibited for use in lactating dairy cows that are producing milk for human consumption and is not recommended for non-lactating dairy cows within two months before calving due to food residue concerns.

Q: Does Vets Choice interact with common blood pressure medications?

A: Official regulatory documentation lists the anticoagulant Warfarin as the only specific drug interaction, noting it may lead to an increased International Normalized Ratio (INR). No interaction with common blood pressure medications is explicitly listed in the product labeling.

Q: Why would a doctor switch a patient from an older drug to Vets Choice?

A: Official labeling highlights several product characteristics, including its broad-spectrum parasite control, its low-volume, pour-on application, and its wide safety margin. These advantages described in the product information may represent factors a veterinarian considers when selecting a treatment option.

How should Vets Choice be stored and disposed of?

How to Store and Dispose of Vets Choice?

Strict adherence to official labeling is required for the storage and disposal of Vets Choice to maintain its efficacy and ensure safety.

Storage and Handling

Requirement Official Instruction
Temperature Store within the specific temperature range (e.g., 2 C to 8 C or below 25 C) as indicated on the package.
Protection Keep the product in its original, light-resistant container and protect it from freezing.
In-Use Stability If applicable, use the product within the official in-use stability period (e.g., X days after first opening); discard any unused portion after this time.
Access Store the medication securely, always out of the reach and sight of children and pets.

Disposal

All expired, unused, or opened products must be disposed of in accordance with local, state, and federal hazardous and clinical waste regulations. Disposal through designated veterinarian or manufacturer take-back programs is often the preferred method. Sharps (e.g., needles) must be placed immediately into approved sharps disposal containers. Do not dispose of the medication by flushing it down a toilet or pouring it down a drain unless explicitly instructed by official disposal guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Vets Choice found in:

A-Z Index: